Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer

Journal of Clinical Epidemiology

Volumn 56, Issue 2, 2003, Pages 155-163

  Lawlor, Debbie A ^a   Jüni, Peter ^a,b   Ebrahim, Shah ^a   Egger, Matthias ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antidepressant medication; Breast cancer; Systematic review

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 0037295588     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00568-1     Document Type: Article

References (31)

1. McPherson K., Steel C.M., Dixon J.M. ABC of breast diseases. Breast cancer - epidemiology, risk factors, and genetics. BMJ. 321:2000;624-628.
2. McManus P., Mant A., Mitchell P.B., Montgomery W.S., Marley J., Auland M.E. Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Med J Aust. 173:2000;458-461.
3. Martin R.M., Hilton S.R., Kerry S.M., Richards N.M. General practitioners' perceptions of the tolerability of antidepressant drugs. a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants BMJ. 314:1997;646-651.
4. Brandes L.J., Arron R.J., Bogdanovic R.P.et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res. 52:1992;3796-3800.
5. Marx J. Do antidepressants promote tumors? Science. 257:1992;22-23. [news].
6. Nemecek S. Backfire. Could Prozac and Elavil promote tumor growth? Sci Am. 271:1994;22-23. [news].
7. Bendele R.A., Adams E.R., Hoffman W.P., Gries C.L., Morton D.M. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res. 52:1992;6931-6935.
8. Turkington R.W. Prolactin secretion in patients treated with various drugs. phenothiazines, tricyclic antidepressants, reserpine, and methyldopa Arch Intern Med. 130:1972;349-354.
9. Krulich L. The effect of a serotonin uptake inhibitor (Lilly 110140) on the sercretion of prolactin in the rat. Life Sci. 17:1975;1141-1144.
10. Nordenberg J., Fenig E., Landau M., Weizman R., Weizman A. Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol. 58:1999;1229-1236.
11. Cotterchio M., Kreiger N., Darlington G., Steingart A. Antidepressant medication use and breast cancer risk. Am J Epidemiol. 151:2000;951-957.
12. Kato I., Zeleniuch-Jacquotte A., Toniolo P.G., Akhmedkhanov A., Koenig K., Shore R.E. Psychotropic medication use and risk of hormone-related cancers. The New York University Women's Health Study J Pub Health Med. 22:2000;155-160.
13. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 52:1998;377-384.
14. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA. 273:1995;408-412.
15. Collet J.-P., Boivin J.-F. Bias and confounding in pharmacoepidemiology. Strom B.L. Pharmacoepidemiology. 2000;765-784 John Wiley & Sons, Ltd; Chichester.
16. Egger M., Davey Smith G. Principles of and procedures for systematic reviews. Egger M., Davey Smith G., Altman D. Systematic reviews in health care. Meta-analysis in context 2nd ed:2001;23-43 BMJ Books; London.
17. Friedman G.D., Habel L.A., Boles M., McFarland B.H. Kaiser Permanent Medical Care Program. Division of Research, Northern California, and Centre for Health Research, Northwest Division Strom B.L. Pharmacoepidemiology. 2000;263-283 John Wiley & Sons, Ltd; Chichester.
18. Van Den Eeden S.K., Friedman G.D. Prescription drug screening for possible carcinogenicity. eleven to fifteen years of follow-up Pharmacoepidemiol Drug Safety. 4:1995;275-287.
19. Selby J.V., Friedman G.D., Fireman B.H. Screening prescription drugs for possible carcinogenicity. eleven to fifteen years of follow-up Cancer Res. 49:1989;5736-5747.
20. Friedman G.D., Ury H.K. Screening for possible drug carcinogenicity. second report of findings J Natl Cancer Inst. 71:1983;1165-1175.
21. Friedman G.D., Ury H.K. Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst. 65:1980;723-733.
22. Wang P.S., Walker A.M., Tsuang M.T., Orav E.J., Levin R., Avorn J. Antidepressant use and the risk of breast cancer. a non-association J Clin Epidemiol. 54:2001;728-734.
23. Danielson D.A., Jick H., Hunter J.R., Stergachis A., Madsen S. Nonestrogenic drugs and breast cancer. Am J Epidemiol. 116:1982;329-332.
24. Sharpe C.R., Collet J.-P., Belzile E., Hanley J.A., Boivin J.-F. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer. 86:2002;92-97.
25. Wallace R.B., Sherman B.M., Bean J.A. A case-control study of breast cancer and psychotropic drug use. Oncology. 39:1982;279-283.
26. Kelly J.P., Rosenberg L., Palmer J.R.et al. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol. 150:1999;861-868.
27. Barbone F., Filiberti R., Franceschi S.et al. Socioeconomic status, migration and the risk of breast cancer in Italy. Int J Epidemiol. 25:1996;479-487.
28. O'Malley M.S., Earp J.A., Hawley S.T., Schell M.J., Mathews H.F., Mitchell J. The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography. who gets the message about breast cancer screening? Am J Public Health. 91:2001;49-54.
29. Thomson C.S., Hole D.J., Twelves C.J., Brewster D.H., Black R.J. Prognostic factors in women with breast cancer. distribution by socioeconomic status and effect on differences in survival J Epidemiol Community Health. 55:2001;308-315.
30. Desai H.D., Jann M.W. Major depression in women. a review of the literature J Am Pharm Assoc (Wash). 40:2000;525-537.
31. Egger M., Davey Smith G., Schneider M. Systematic reviews of observational studies. Egger M., Davey Smith G., Altman D.G. Systematic reviews in health care. meta-analysis in context 2nd ed:2001;211-227 BMJ Books; London.